Search results
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 4 days agoModerna said on Monday that its experimental combination vaccines against COVID-19 and the flu...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 4 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoModerna representatives told news outlets that the company aspires to have the new shot approved by...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 1 day agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 3 days agovaccine. Novavax's candidate already has delivered positive results from its phase 2 trial and the...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoWeik Capital Management decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent filing with ...
The FDA tells COVID-19 vaccine makers to update shot to target newest variant
KSL TV Utah· 6 days agoThe FDA told the advisory committee Wednesday that studies have shown that the currently available ...
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA Today· 3 days agoThe Centers for Disease Control and Prevention said it is tracking the new COVID variant KP.3 as data shows its dominance across the United States. For the two-week period ...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 3 days agoThe ongoing clinical trial pits this new combination shot, called mRNA-1083, against several licensed vaccines that protect against either COVID-19 or the ...